 | • レポートコード：C-MOR-100058 • 出版社/出版日：Mordor Intelligence / 2019年9月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Multi User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site License | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、血液分析装置の世界市場について調査・分析し、血液分析装置の世界市場規模、市場動向、市場環境分析、市場展望、セグメント別分析、地域別分析、関連企業情報など以下の構成でお届け致します。 |
Market Overview
The major factors for the growth of the hematology analyzers market include the rising burden of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments.
Blood disorders have become a global health issue with different causes, and are associated with high mortality. Blood disorders, such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, affect millions of people each year across all age groups. According to Commonwealth of Australia, more than 330,000 affected infants are born each year (83% sickle cell disorders and 17% thalassaemias), around 7% of pregnant women are carriers of hemoglobin disorders and over 1% of couples are at risk at a global level. The National Institute of Health (NIH) has stated that, in 2011, Anemia affects 29% of women with reproductive age and 38% of pregnant women worldwide. As per the World Federation of Hemophilia, 184,723 people were affected with Hemophilia in 2016, along with 39,495 people with other bleeding disorders. Early diagnosis and treatment are the best ways to protect the quality of life for a patient with a blood cell disorder. Hence, the increasing burden of blood disorders is likely to drive the market in the future.
Scope of the Report
As per the scope of this report, hematology analyzers are the equipment used to run tests on blood samples and they are used in the medical field to determine white blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests. The market is segmented by product type, end-user, and geography.
Key Market Trends
Clinical Testing Laboratories is the Segment by End-User expected to Hold Largest Market Share
The clinical laboratories as end-users are the centers where hematology tests are performed. Usually, they have high-quality equipment and the results obtained from them are accurate. The automation of laboratories have increased the equipment costs in this segment, however, the analyzers are not frequently replaced in these laboratories. The clinical testing laboratories perform various tests on whole blood, serum, urine, cerebrospinal fluids, and other body fluids. Furthermore, convenience and accurate results are the two major reasons driving the growth of the segment over the forecast period.
North America is Expected to Dominate the Market Studied
The market for hematology analyzers in the United States is growing at a steady pace. This can be attributed to the increasing burden of blood disorders and the growth in adoption of hematology analyzers by the diagnostic industry. For instance, anemia, which is a common disorder, affects more than three million Americans, particularly women of ‘childbearing-age’. In the United States, there are a number of associations helping, both, clinicians and scientists across the world, who are working to conquer such blood diseases. In addition, many centers in the state are international leaders in the diagnosis and treatment of blood diseases and collaborate in many research projects to improve diagnosis and treatment options for blood diseases. These factors drive the demand and importance of allergy immunotherapy medication in the North American region.
Competitive Landscape
The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Beckman Coulter, Inc., Bio-Rad Laboratories, Boule Diagnostics AB, F. Hoffmann-La Roche Ltd, Hobira Ltd, Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers, and Sysmex Corporation
Reasons to Purchase this report:
The market estimate (ME) sheet in Excel format
Report customization as per the client’s requirements
3 months of analyst support
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Blood Disorders
4.2.2 Increasing Technological Advancements
4.2.3 Rising Adoption Rates of Automated Hematology Instruments
4.3 Market Restraints
4.3.1 High Cost of Hematology Analyzers
4.3.2 Time-consuming and Stringent Rregulatory Policies
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Instruments
5.1.1.1 3 Part Hematology Analyzer
5.1.1.2 5 Part Hematology Analyzer
5.1.1.3 Point-of-Care Testing Hematology Analyzers
5.1.1.4 Others
5.1.2 Reagents
5.1.2.1 Hematology Reagents
5.1.2.2 Slide Stainers/Makers
5.1.2.3 Others
5.1.3 Services
5.2 By End User
5.2.1 Hospitals
5.2.2 Clinical Laboratories
5.2.3 Research Institutes
5.2.4 Others
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Beckman Coulter, Inc.
6.1.3 Bio-Rad Laboratories
6.1.4 Boule Diagnostics AB
6.1.5 F. Hoffmann-La Roche Ltd
6.1.6 Horiba Ltd
6.1.7 Nihon Kohden Corporation
6.1.8 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
6.1.9 Siemens Healthineers
6.1.10 Sysmex Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS